JP2022521705A5 - - Google Patents
Info
- Publication number
- JP2022521705A5 JP2022521705A5 JP2021547303A JP2021547303A JP2022521705A5 JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5 JP 2021547303 A JP2021547303 A JP 2021547303A JP 2021547303 A JP2021547303 A JP 2021547303A JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- sequence number
- antigen
- sequences
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024229509A JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941005395 | 2019-02-11 | ||
| IN201941005395 | 2019-02-11 | ||
| PCT/US2020/017518 WO2020167668A1 (en) | 2019-02-11 | 2020-02-10 | Anti-clec2d antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024229509A Division JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022521705A JP2022521705A (ja) | 2022-04-12 |
| JP2022521705A5 true JP2022521705A5 (https=) | 2023-02-20 |
| JP7612591B2 JP7612591B2 (ja) | 2025-01-14 |
Family
ID=69811875
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547303A Active JP7612591B2 (ja) | 2019-02-11 | 2020-02-10 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
| JP2024229509A Pending JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024229509A Pending JP2025062598A (ja) | 2019-02-11 | 2024-12-25 | 抗ｃｌｅｃ２ｄ抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11827710B2 (https=) |
| EP (1) | EP3924385A1 (https=) |
| JP (2) | JP7612591B2 (https=) |
| KR (1) | KR20220007584A (https=) |
| AU (1) | AU2020222891A1 (https=) |
| CA (1) | CA3129818A1 (https=) |
| IL (1) | IL285401A (https=) |
| NZ (1) | NZ778293A (https=) |
| SG (1) | SG11202108403UA (https=) |
| WO (1) | WO2020167668A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220007584A (ko) | 2019-02-11 | 2022-01-18 | 주무토르 바이오로직스 인코포레이티드 | 항-clec2d 항체 및 이의 사용 방법 |
| CN115443140A (zh) * | 2020-04-02 | 2022-12-06 | 苏州恒康生命科学有限公司 | 人ror-1抗体和抗ror-1-car-t细胞 |
| CN116547003A (zh) * | 2020-10-05 | 2023-08-04 | 莫纳什大学 | Clec9a抗体 |
| WO2022202985A1 (ja) * | 2021-03-24 | 2022-09-29 | 森永乳業株式会社 | ペプチド、及び該ペプチドを有効成分として含有する組成物 |
| WO2023039242A2 (en) * | 2021-09-13 | 2023-03-16 | Achelois Biopharma, Inc. | Multivalent interferon particles compositions and methods of use |
| CN114685663B (zh) * | 2022-04-07 | 2023-09-08 | 西南大学 | 一种抗胆固醇依赖性细胞溶素的抗体及其应用 |
| PE20251175A1 (es) * | 2022-05-31 | 2025-04-23 | Pfizer | Anticuerpos anti-bmp9 y metodos de uso de los mismos |
| CN120129704A (zh) * | 2022-11-01 | 2025-06-10 | 俄勒冈州健康与服务部 | 特异于fas配体的单克隆抗体及其用途 |
| CN115894675B (zh) * | 2023-02-03 | 2023-11-14 | 康复大学(筹) | 新冠病毒SARS-CoV-2核衣壳蛋白单克隆抗体及其应用 |
| KR20260017010A (ko) * | 2023-04-24 | 2026-02-04 | 엘피스 바이오파마슈티컬즈 | 장갑 항-b7h3 car-t 세포 및 암 치료에 있어서의 그 용도 |
| WO2025096542A2 (en) * | 2023-10-30 | 2025-05-08 | Immunitas Therapeutics, Inc. | Clec2d binding proteins and related methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| EP0745134A1 (en) | 1994-02-22 | 1996-12-04 | Danafarber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| US7147854B2 (en) | 1997-06-23 | 2006-12-12 | Yes Biotech Laboratories Ltd. | Topical treatment of psoriasis using neutralizing antibodies to interleukin-8 |
| US20040001804A1 (en) * | 1999-12-30 | 2004-01-01 | Mathew Porunelloor A. | LLT uses thereof in immune system modulation |
| EP3443981B1 (en) * | 2010-06-29 | 2021-03-10 | Centre National de la Recherche Scientifique (CNRS) | Llt-1 antibodies with new functional properties |
| US9111624B2 (en) | 2013-03-22 | 2015-08-18 | Katsuyuki Fujita | Semiconductor memory device |
| KR20220007584A (ko) * | 2019-02-11 | 2022-01-18 | 주무토르 바이오로직스 인코포레이티드 | 항-clec2d 항체 및 이의 사용 방법 |
-
2020
- 2020-02-10 KR KR1020217029054A patent/KR20220007584A/ko active Pending
- 2020-02-10 EP EP20711372.1A patent/EP3924385A1/en active Pending
- 2020-02-10 NZ NZ778293A patent/NZ778293A/en unknown
- 2020-02-10 WO PCT/US2020/017518 patent/WO2020167668A1/en not_active Ceased
- 2020-02-10 AU AU2020222891A patent/AU2020222891A1/en active Pending
- 2020-02-10 JP JP2021547303A patent/JP7612591B2/ja active Active
- 2020-02-10 CA CA3129818A patent/CA3129818A1/en active Pending
- 2020-02-10 SG SG11202108403UA patent/SG11202108403UA/en unknown
- 2020-02-10 US US16/786,391 patent/US11827710B2/en active Active
-
2021
- 2021-08-05 IL IL285401A patent/IL285401A/en unknown
-
2023
- 2023-05-08 US US18/314,117 patent/US12460007B2/en active Active
-
2024
- 2024-12-25 JP JP2024229509A patent/JP2025062598A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521705A5 (https=) | ||
| JP7098629B2 (ja) | 抗ｐｄ－１モノクローナル抗体、その製造方法及び用途 | |
| JP2022008382A5 (https=) | ||
| TWI769537B (zh) | 標靶ｂｃｍａ的抗體、雙專一性抗體及其用途 | |
| HRP20210739T1 (hr) | Molekule koje vežu antigen i sadrže trimer obitelji tnf liganada | |
| CA3222764A1 (en) | Anti-ccr8 antibodies and uses thereof | |
| CN112574307A (zh) | 抗人Claudin18.2抗体及其应用 | |
| TWI777056B (zh) | 結合至ssea4的單株抗體及其用途 | |
| CN114206931B (zh) | 抗pd-1抗体及其用途 | |
| JP2020510422A5 (https=) | ||
| PH12020551173A1 (en) | Anti-pd-l1 antibodies and uses thereof | |
| RU2019128134A (ru) | Антитело против gprc5d и молекула, содержащая антитело | |
| JP2018523493A5 (https=) | ||
| JP2022504802A5 (https=) | ||
| RU2018106452A (ru) | Поливалетные и полиспецифичные gitr-связывающие слитые белки | |
| JP2018503380A5 (https=) | ||
| JP2018518540A5 (https=) | ||
| JP2012501670A5 (https=) | ||
| CN108164600B (zh) | 一种抗gpc3抗体及其制备方法和用途 | |
| JP2020514277A5 (https=) | ||
| US20240101675A1 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof | |
| JP2013527762A5 (https=) | ||
| JP2024530451A (ja) | 抗ｐｖｒｉｇ／抗ｔｉｇｉｔ二重特異性抗体及び応用 | |
| JP2023511898A5 (https=) | ||
| CA3069238A1 (en) | Bispecific antibodies and methods of making and using thereof |